DuPont invests in DuPont™ Liveo™ brand healthcare silicone solutions to broaden its range of specialty medical adhesives. DuPont is investing to strengthen strategic capabilities in innovation, as well as in manufacturing capabilities.
Addressing Challenges of Healthcare Market
The investments will address the key challenges and opportunities in three primary healthcare market segments, namely:
-
Medical Devices, to enable safe, convenient and effective diagnostics, monitoring
and treatment at the point of care with a broadening range of specialty medical adhesives and elastomers to support the trend for connected devices and wearables.
-
Biopharma Processing, to enable cost-effective, safe manufacturing of biologics used in innovative drugs and vaccines with a wide range of Liveo™ pharma tubing and overmolded assemblies.
-
Pharmaceutical Solutions, to enable safe, effective new therapeutic drug delivery routes with a unique offering in topical and transdermal solutions, and gastrointestinal active pharmaceutical ingredients.
Investments to Accelerate Business Growth
The investments are focused on accelerating business growth, addressing key industry challenges arising from global megatrends, and continually improving and expanding DuPont’s ability to serve customers.
To support customer growth and accelerate new product introductions, the targeted investments include, increasing supply capacities with manufacturing improvements at DuPont’s Healthcare Industries Materials Site (HIMS) in Hemlock, Michigan, USA. Notable upgrades include, extrusion capacity expansion for tubing, a new ISO 7 cleanroom, and ongoing elastomer capacity expansions with new mixing equipment for liquid silicone rubber (LSR) and high-consistency rubber (HCR).
“
The investments will help strengthen and grow the value of our DuPont™ Liveo™ brand healthcare silicone solutions,” said DuPont™ Liveo™ Healthcare global business director Eugenio Toccalino.
Source: DuPont